POM

Pomdoctor Ltd

1.85

Nov 02 • 3:59 PM ET +0.31 (20.13%)

1.74

Aftermarket • 7:58 PM ET -0.11 (-6.00%)

Healthcare Pharmaceutical Retailers China Nano NASD

Today, 4:10 PMPomdoctor receives Nasdaq Global Market noncompliance notices, given until April 26 2027 to regain listing requirements

Peers: RDGT YI PETS LFMD MNDR HIMS GDRX TDOC AMWL UPC

Scroll to Statements

Index	-
Market Cap	15.43M
Enterprise Value	24.16M
Income	-
Sales	-
Book/sh	-1.47
Cash/sh	0.03
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	165
IPO	Oct 08, 2025

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	-
P/C	57.14
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	0.32
Current Ratio	0.35
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / Yes

EPS (ttm)	-
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	-47.90% -10.17%
Sales past 3/5Y	15.17% 22.15%
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-
Sales Q/Q	-
Earnings	May 14 AMC
EPS/Sales Surpr.	- -

Insider Own	-
Insider Trans	-
Inst Own	0.03%
Inst Trans	-
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-12.86%
SMA50	-28.30%
SMA200	-80.52%
Trades

Shs Outstand	6.34M
Shs Float	-
Short Float	-
Short Ratio	0.00
Short Interest	0.01M
52W High	385.80 -99.52%
52W Low	0.69 168.12%
Volatility	45.49% 50.07%
ATR (14)	0.70
RSI (14)	46.23
Beta	3.25
Rel Volume	0.26
Avg Volume	1.94M
Volume	504,052

Perf Week	63.72%
Perf Month	-35.47%
Perf Quarter	-23.18%
Perf Half Y	-91.89%
Perf YTD	-89.54%
Perf Year	-99.43%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	1.54
Price	1.85
Change %	20.13%

Today 04:05PM	POMDOCTOR LIMITED Announces Receipt of Nasdaq Notifications Regarding Continued Listing Requirements (PR Newswire) +20.13% -6.00%
Oct-19-26 08:30AM	POMDOCTOR LIMITED Announces the Termination of Its ADR Program and Trade Class A Ordinary Shares on Nasdaq (PR Newswire) -15.88%
Oct-12-26 08:00AM	POMDOCTOR LIMITED Highlights the Shift from Reactive Treatment to Predictive Healthcare (PR Newswire) -19.35%
Oct-09-26 04:05PM	POMDOCTOR LIMITED Announces Receipt of Nasdaq Staff Delisting Determination (PR Newswire)
Sep-30-26 08:00AM	POMDOCTOR LIMITED Accelerates AI-Enabled Chronic Disease Management and RWD Commercialization (PR Newswire)
08:00AM	Loading…
Sep-24-26 08:00AM	POMDOCTOR LIMITED Highlights Differentiated "Hardware + AI + Payment" Healthcare Infrastructure Model (PR Newswire) +21.23%
Sep-10-26 08:00AM	POMDOCTOR LIMITED to Participate in H.C. Wainwright's 28th Annual Global Investment Conference (PR Newswire) +5.52%
Aug-27-26 08:00AM	POMDOCTOR LIMITED Initiates U.S. Market Preparation and Unveils Expansion Strategy (PR Newswire)
Aug-10-26 08:00AM	POMDOCTOR LIMITED Highlights Healthcare Intelligence Flywheel as a Self-Reinforcing Growth Engine (PR Newswire) +26.01%
Aug-03-26 08:00AM	POMDOCTOR LIMITED Highlights Four-Tier Diversified Revenue Structure (PR Newswire) +25.00%
Jul-15-26 08:00AM	POMDOCTOR LIMITED Advances Healthcare Data Asset Strategy to Strengthen AI-Powered Chronic Disease Management Capabilities (PR Newswire)
Jul-13-26 08:00AM	POMDOCTOR LIMITED Regains Compliance with Nasdaq Bid Price Requirement (PR Newswire) -7.19%
Jul-09-26 08:00AM	POMDOCTOR LIMITED Continues to Advance AI-Enabled Chronic Disease Management Strategy Amid Growing Demand for Predictive Healthcare (PR Newswire) +13.79%
Jul-02-26 08:00AM	POMDOCTOR LIMITED Announces Strategic Upgrade Toward Infrastructure for Predictive Healthcare Data and Services (PR Newswire)
Jun-17-26 06:00AM	POMDOCTOR LIMITED Announces ADS Ratio Change to Be Effective on June 22, 2026 (PR Newswire)
08:00AM	Loading…
May-28-26 08:00AM	POMDOCTOR LIMITED Announces Plan to Implement ADS Ratio Change (PR Newswire) -8.22%
May-14-26 04:30PM	POMDOCTOR LIMITED Announces Fiscal Year 2025 Financial Results (PR Newswire) -8.51%
Mar-13-26 08:00AM	POMDOCTOR LIMITED Announces Strategic Upgrade, Focusing on "AI + Medical-Grade Smart Wearables" to Build a New Ecosystem for Full-Cycle Chronic Disease Management (PR Newswire)
Feb-11-26 12:15PM	Shareholders who lost money in American Depositary Receipts of PomDoctor, Ltd. (NASDAQ: POM) Should Contact Wolf Haldenstein Immediately (PR Newswire)
Feb-04-26 08:00AM	POMDOCTOR LIMITED Expands Platform Integration With Online Medical Insurance Coverage Across Major Chinese Cities (PR Newswire)
Feb-02-26 06:00AM	POMDOCTOR LIMITED Announces Receipt of Nasdaq Notice (PR Newswire) +5.15%
Jan-16-26 09:00AM	POMDOCTOR LIMITED Drive Internet Hospital Growth Through Strengthened Strategic Partnerships With Pharmaceutical Companies (PR Newswire)
Dec-03-25 04:15PM	POMDOCTOR LIMITED Announces First Half of Fiscal 2025 Unaudited Financial Results (PR Newswire) +5.36%
Oct-10-25 05:15PM	POMDOCTOR LIMITED Announces Full Exercise and Closing of Underwriter's Over-Allotment Option (PR Newswire) -8.81%
02:57PM	Should You Buy POM Stock After the PomDoctor IPO? (Barchart)
Oct-09-25 04:05PM	POMDOCTOR LIMITED Announces Closing of Initial Public Offering (PR Newswire) +18.36%
Oct-08-25 08:00AM	POMDOCTOR LIMITED Announces Pricing of Initial Public Offering (PR Newswire)

Show Previous News

PomDoctor Ltd. operates as an online medical services platform, which specializes in chronic disease management and pharmaceutical services. It operates through two segments: Internet hospital and pharmaceutical supply chain. The Internet hospital segment include online consultation and prescription renewal and CDM service. The pharmaceutical supply chain provides other pharmaceutical platforms with supply chain management and platform operation services. The company was founded by Zhenyang Shi and Li Xu on February 01, 2021 and is headquartered in Guangzhou, China.

Co-FounderMr. Zhenyang Shi

Co-Founder & CFOMs. Li Xu

VP & DirectorMr. Guoji Luo

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

POM

Pomdoctor Ltd

Upgrade your Finviz experience